VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,767 | -23.8% | 22,067 | +99.4% | 0.00% | -66.7% |
| Q2 2023 | $271,473 | +5.4% | 11,067 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $257,529 | -8.1% | 11,067 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $280,105 | +31.5% | 11,067 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $213,000 | -24.5% | 11,067 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $282,000 | -1.1% | 11,067 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $285,000 | -38.4% | 11,067 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $463,000 | +112.4% | 11,067 | +121.3% | 0.00% | +100.0% |
| Q3 2021 | $218,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |